MICHAEL DAN, M.D.; JOEL GREIF, M.D.
To the editor: The question of whether amiodarone-induced pneumonitis should be treated with corticosteroids will be resolved only by a controlled trial comparing steroid treatment with placebo. Until then, the sole source of information is cumulative experience with scattered patients. Our recent experience with a patient with amiodarone-induced pneumonitis does not support the suggestion made by Dake and associates (1) that steroid treatment for this disorder may not be needed.
A 63-year old woman was maintained on amiodarone, 200 mg/d, to prevent paroxysmal atrial fibrillation. After 3 years of therapy, she began to develop increasing fatigue, mild dyspnea
DAN M, GREIF J. Amiodarone and Pneumonitis. Ann Intern Med. ;99:732. doi: 10.7326/0003-4819-99-5-732_1
Download citation file:
Published: Ann Intern Med. 1983;99(5):732.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use